[1] Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS-MAPK
pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci. 2010; 1214:99-121
[2] Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract
Res Clin Endocrinol Metab. 2011; 25:161-79
[3] Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello
syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A.
2019;179:1725-1744
[4] Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, et al. Cardio-facio
cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics.
2014;134:e1149-e1162
[5] Stevenson DA, Yang FC. The musculoskeletal phenotype of the RASopathies. Am J Med Genet
C Semin Med Genet. 2011;157:90-103
[6] Rhodes SD, Zhang W, Yang D, Yang H, Chen S, Wu X et al. Dystrophic spinal deformities in a
neurofibromatosis type 1 murine model. PLoS One. 2015; 10:e0119093
[7] Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis
type 1. Nat Rev Dis Primers. 2017; 3:17004
[8] Yassir WK, Grottkau BE, Goldberg MJ. Costello syndrome: orthopaedic manifestations and
functional health. J Pediatr Orthop. 2003; 23:94–98
[9] White SM, Graham JM, Jr, Kerr B, Gripp K, Weksberg R, Cytrynbaum C et al. The adult
phenotype in Costello syndrome. Am J Med Genet A. 2005; 136:128–135
[10] Armour CM, Allanson JE. Further delineation of cardio-facio-cutaneous syndrome: clinical
features of 38 individuals with proven mutations. J Med Genet. 2008; 45:249–254
[11] Reinker KA, Stevenson DA e Tsung A. Orthopaedic conditions in Ras/MAPK related
disorders. J Pediatr Orthop. 2011; 31:599-605
[12] Stevenson DA, Allen S, Tidyman WE, Carey JC, Viskochil DH, Stevens A et al. Peripheral
muscle weakness in RASopathies. Muscle Nerve. 2012; 46:394-9
[13] Detweiler S, Thacker MM, Hopkins E, Conway L, Gripp KW. Orthopedic manifestations and
implications for individuals with Costello syndrome. Am J Med Genet Part A. 2013; 161:1940-
1949
[14] Gripp KW, Lin AE, Stabley DL, Nicholson L, Scott CI, Jr, Doyle D et al. HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am J Med Genet Part A. 2006; 140:1-7.
[15] Leoni C, Giorgio V, Onesimo R, Kuczynska E, Zampino G. Impact of Costello syndrome on growth patterns. Am J Med Genet Part A. 2020; doi: 10.1002/ajmg.a.61812
[16] Johnson B, Goldberg-Strassler D, Gripp K, Thacker M, Leoni C, Stevenson D. Function and
disability in children with Costello syndrome and Cardiofaciocutaneous syndrome. Am J Med
Genet A. 2014; 167:40-4
[17] Axelrad ME, Schwartz DD, Katzenstein JM, Hopkins E, Gripp KW. Neurocognitive, adaptive
and behavioral functioning of individuals with Costello syndrome: a review. Am J Med Genet C
Semin Med Genet. 2011; 157:115-122
[18] American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J
Respir Crit Care Med. 2002; 166:111–117
[19] Daltroy LH, Liang MH, Fossel AH, Goldberg MJ. The POSNA pediatric musculoskeletal
functional health questionnaire: report on reliability, validity, and sensitivity to change. Pediatric
Outcomes Instrument Development Group. Pediatric Orthopaedic Society of North America. J
Pediatr Orthop. 1998; 18:561-71
[20] Haynes RJ and Sullivan E. The Pediatric Orthopaedic Society of North America pediatric
orthopaedic functional health questionnaire: an analysis of normal. J Pediatr Orthop. 2001; 21:619
621
[21] Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-minute walk test
in children and adolescents. J Pediatr. 2007; 150:395-9
[22] Jenkins S, Cecins N, Camarri B, Williams C, Thompson P, Eastwood P. Regression equations
to predict 6-minute walk distance in middle-aged and elderly adults. Physiother Theory Pract. 2009;
25:516-22
[23] Tidyman WE, Lee HS e Rauen KA. Skeletal muscle pathology in Costello and Cardio-Facio
Cutaneous Syndromes: developmental consequences of germline Ras/MAPK activation on
myogenesis. Am J Med Genet Part C. 2011; 157: 104-114
[24] Jo C, Jang BG, Jo SA. MEK1 plays contrary stage-specific roles in skeletalmyogenic
differentiation. Cell Signal. 2009; 21:1910-7
[25] Leoni C, Triumbari EKA, Vollono C, Onesimo R, Podagrosi M, Giorgio V, et al. Pain in
individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected
patients. Am J Med Genet A. 2019;179:940-947
[26] Alfieri P, Piccini G, Caciolo C, Perrino F, Gambardella ML, Mallardi M, et al. Behavioral
profile in RASopathies. Am J Med Genet A. 2014; 164:934-42
[27] Yoon G, Rosenberg J, Blaser S, Rauen KA. Neurological complications of cardio-facio
cutaneous syndrome. Dev Med Child Neurol. 2007; 49:894-9
[28] Dileone M, Zampino G, Profice P, Pilato F, Leoni C, Ranieri F et al. Dystonia in Costello
syndrome. Parkinsonism Relat Disord. 2012;18:798-800
[29] Leoni C, Stevenson DA, Martini L, De Sanctis R, Mascolo G, Pantaleoni F, et al. Decreased
bone mineral density in Costello syndrome. Mol Genet Metab. 2014;111:41-45